MedPath

Role of aspirin in Live donor liver transplant(LDLT) in preventing acute cellular rejection(ACR)

Phase 4
Registration Number
CTRI/2023/07/055081
Lead Sponsor
Amrita Institute of Medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients who are undergoing LDLT in our institute

Exclusion Criteria

1 . Paediatric patients (age <18 years)

2. Re-transplantations

3. Patients not willing to participate in the study

4. If PLT <50,000/ul. after 2 weeks after surgery

5. Multiorgan transplants

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath